Cargando…

Influenza vaccine uptake among children and older adults in China: a secondary analysis of a quasi-experimental study

BACKGROUND: Influenza vaccination is the key to prevent influenza-related disease, especially among high-risk populations. However, influenza vaccine uptake in China is low. This secondary analysis of a quasi-experimental trial aimed to understand factors associated with influenza vaccine uptake amo...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Yumeng, Jin, Chenqi, Jit, Mark, Chantler, Tracey, Lin, Leesa, Larson, Heidi J., Li, Jing, Gong, Wenfeng, Yang, Fan, Ren, Nina, Cheng, Weibin, Zhou, Yi, Tang, Weiming, Tucker, Joseph D., Wu, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098986/
https://www.ncbi.nlm.nih.gov/pubmed/37055738
http://dx.doi.org/10.1186/s12879-023-08145-8
_version_ 1785024947758825472
author Du, Yumeng
Jin, Chenqi
Jit, Mark
Chantler, Tracey
Lin, Leesa
Larson, Heidi J.
Li, Jing
Gong, Wenfeng
Yang, Fan
Ren, Nina
Cheng, Weibin
Zhou, Yi
Tang, Weiming
Tucker, Joseph D.
Wu, Dan
author_facet Du, Yumeng
Jin, Chenqi
Jit, Mark
Chantler, Tracey
Lin, Leesa
Larson, Heidi J.
Li, Jing
Gong, Wenfeng
Yang, Fan
Ren, Nina
Cheng, Weibin
Zhou, Yi
Tang, Weiming
Tucker, Joseph D.
Wu, Dan
author_sort Du, Yumeng
collection PubMed
description BACKGROUND: Influenza vaccination is the key to prevent influenza-related disease, especially among high-risk populations. However, influenza vaccine uptake in China is low. This secondary analysis of a quasi-experimental trial aimed to understand factors associated with influenza vaccine uptake among children and older people stratified by funding context. METHODS: A total of 225 children (aged 0.5-8 years) and 225 older people (aged 60 years or above) were recruited from three clinics (rural, suburban and urban) in Guangdong Province. Participants were allocated into two groups based on funding contexts: a self-paid group (N = 150, 75 children and 75 older adults) in which participants paid full price for their vaccination; and a subsidized group (N = 300, 150 children and 150 older adults) in which varying levels of financial support was provided. Univariate and multivariable logistic regressions were conducted stratified by funding contexts. RESULTS: Overall, 75.0% (225/300) of participants in the subsidized group and 36.7% (55/150) in the self-paid group got vaccinated. Older adults had lower vaccination rates than children in both funding groups, while both age groups showed much higher uptake in the subsidized group than in the self-paid group (aOR = 5.96, 95% CI: 3.77–9.42, p = 0.001). In the self-paid group, having prior influenza vaccination history of children (aOR:2.61, 95%CI: 1.06–6.42) or older people (aOR:4.76, 95%CI: 1.08–20.90) was associated with increased influenza vaccine uptake compared to those who had no prior vaccination experiences in the family. While in the subsidized group, participants who got married or lived with partners (aOR = 0.32, 0.10–0.98) had lower vaccination uptake than single ones. Trust in providers’ advice (aOR = 4.95, 95%CI:1.99, 12.43), perceived effectiveness of the vaccine (aOR: 12.18, 95%CI: 5.21–28.50), and experienced influenza-like illnesses in the family in the past year (aOR = 46.52, 4.10, 533.78) were associated with higher vaccine uptake. CONCLUSIONS: Older people had suboptimal vaccine uptake compared to children in both contexts and need more attention to enhance influenza vaccination. Tailoring interventions to different vaccine funding contexts may help improve influenza vaccination: In self-paid context, motivating people to accept their first ever influenza vaccination may be a promising strategy. In subsidized context, improving public confidence in vaccine effectiveness and providers’ advice would be useful. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08145-8.
format Online
Article
Text
id pubmed-10098986
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100989862023-04-14 Influenza vaccine uptake among children and older adults in China: a secondary analysis of a quasi-experimental study Du, Yumeng Jin, Chenqi Jit, Mark Chantler, Tracey Lin, Leesa Larson, Heidi J. Li, Jing Gong, Wenfeng Yang, Fan Ren, Nina Cheng, Weibin Zhou, Yi Tang, Weiming Tucker, Joseph D. Wu, Dan BMC Infect Dis Research BACKGROUND: Influenza vaccination is the key to prevent influenza-related disease, especially among high-risk populations. However, influenza vaccine uptake in China is low. This secondary analysis of a quasi-experimental trial aimed to understand factors associated with influenza vaccine uptake among children and older people stratified by funding context. METHODS: A total of 225 children (aged 0.5-8 years) and 225 older people (aged 60 years or above) were recruited from three clinics (rural, suburban and urban) in Guangdong Province. Participants were allocated into two groups based on funding contexts: a self-paid group (N = 150, 75 children and 75 older adults) in which participants paid full price for their vaccination; and a subsidized group (N = 300, 150 children and 150 older adults) in which varying levels of financial support was provided. Univariate and multivariable logistic regressions were conducted stratified by funding contexts. RESULTS: Overall, 75.0% (225/300) of participants in the subsidized group and 36.7% (55/150) in the self-paid group got vaccinated. Older adults had lower vaccination rates than children in both funding groups, while both age groups showed much higher uptake in the subsidized group than in the self-paid group (aOR = 5.96, 95% CI: 3.77–9.42, p = 0.001). In the self-paid group, having prior influenza vaccination history of children (aOR:2.61, 95%CI: 1.06–6.42) or older people (aOR:4.76, 95%CI: 1.08–20.90) was associated with increased influenza vaccine uptake compared to those who had no prior vaccination experiences in the family. While in the subsidized group, participants who got married or lived with partners (aOR = 0.32, 0.10–0.98) had lower vaccination uptake than single ones. Trust in providers’ advice (aOR = 4.95, 95%CI:1.99, 12.43), perceived effectiveness of the vaccine (aOR: 12.18, 95%CI: 5.21–28.50), and experienced influenza-like illnesses in the family in the past year (aOR = 46.52, 4.10, 533.78) were associated with higher vaccine uptake. CONCLUSIONS: Older people had suboptimal vaccine uptake compared to children in both contexts and need more attention to enhance influenza vaccination. Tailoring interventions to different vaccine funding contexts may help improve influenza vaccination: In self-paid context, motivating people to accept their first ever influenza vaccination may be a promising strategy. In subsidized context, improving public confidence in vaccine effectiveness and providers’ advice would be useful. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-023-08145-8. BioMed Central 2023-04-13 /pmc/articles/PMC10098986/ /pubmed/37055738 http://dx.doi.org/10.1186/s12879-023-08145-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Du, Yumeng
Jin, Chenqi
Jit, Mark
Chantler, Tracey
Lin, Leesa
Larson, Heidi J.
Li, Jing
Gong, Wenfeng
Yang, Fan
Ren, Nina
Cheng, Weibin
Zhou, Yi
Tang, Weiming
Tucker, Joseph D.
Wu, Dan
Influenza vaccine uptake among children and older adults in China: a secondary analysis of a quasi-experimental study
title Influenza vaccine uptake among children and older adults in China: a secondary analysis of a quasi-experimental study
title_full Influenza vaccine uptake among children and older adults in China: a secondary analysis of a quasi-experimental study
title_fullStr Influenza vaccine uptake among children and older adults in China: a secondary analysis of a quasi-experimental study
title_full_unstemmed Influenza vaccine uptake among children and older adults in China: a secondary analysis of a quasi-experimental study
title_short Influenza vaccine uptake among children and older adults in China: a secondary analysis of a quasi-experimental study
title_sort influenza vaccine uptake among children and older adults in china: a secondary analysis of a quasi-experimental study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10098986/
https://www.ncbi.nlm.nih.gov/pubmed/37055738
http://dx.doi.org/10.1186/s12879-023-08145-8
work_keys_str_mv AT duyumeng influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT jinchenqi influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT jitmark influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT chantlertracey influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT linleesa influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT larsonheidij influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT lijing influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT gongwenfeng influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT yangfan influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT rennina influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT chengweibin influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT zhouyi influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT tangweiming influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT tuckerjosephd influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy
AT wudan influenzavaccineuptakeamongchildrenandolderadultsinchinaasecondaryanalysisofaquasiexperimentalstudy